The neuromelanin of human substantia nigra and its interaction with metals

Journal of Neural Transmission

Volumn 109, Issue 5-6, 2002, Pages 663-672

  Zecca, L ^a   Tampellini, D ^a   Gatti, A ^a   Crippa, R ^c   Eisner, M ^d   Sulzer, D ^e,f   Ito, S ^b   Fariello, R ^g   Gallorini, M ^h  

^a CNR   (Italy)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c UNIVERSITY OF PARMA   (Italy)

^d University of Houston   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^g Newron Pharmaceuticals   (Italy)

^h UNIVERSITY OF PAVIA   (Italy)

Author keywords

Aging; Metals; Neuromelanin; Parkinson's disease; Substantia nigra

Indexed keywords

COPPER; IRON; METAL; NEUROMELANIN; ZINC;

ARTICLE; BRAIN LEVEL; BRAIN NERVE CELL; CELL CULTURE; CELL SURVIVAL; DOPAMINERGIC NERVE CELL; ELECTRON SPIN RESONANCE; HUMAN; IRON CHELATION; NEUROPROTECTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBSTANTIA NIGRA; X RAY DIFFRACTION;

DRUG INTERACTIONS; HUMANS; IRON; MELANINS; METALS; SUBSTANTIA NIGRA;

EID: 0036326167     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020200055     Document Type: Article

References (71)

1. Melanin pigment in the central nervous system vertebrates
2. Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for enhanced iron sequestering ability of substantia nigra
3. EPR investigations of the iron domain in neuromelanin
4. Histochemical relationship and nature of neuromelanin
5. Iron-melanin interaction and lipid peroxidation: Implications for Parkinson's disease
6. A brainstem atlas of catecolaminergic neurons in man, using melanin as a natural marker
7. The structure of neuromelanin and its iron binding site studied by infrared spectroscopy
8. The neuromelanin of the human substantia nigra
9. X-Ray characterization of melanins-II
10. Melanogenesis and extrapiramidal disorders
11. The melanoneurons of the human cerebellum (nucleus pigmentosus cerebellaris) and homologues in the monkey
12. A spectroscopy study of the equine brain melanins
13. Structure of human neuromelanin by X-Ray diffraction: Comparison with synthetics
14. + binds to neuromelanin
15. Neuromelanic pigment in substantia nigra neurons of rats and dogs
16. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
17. Biosynthesis, structure and function of neuromelanin and its relation to Parkinson's disease: A critical update
18. Role of iron in 6-hydroxydopamine neurotoxicity
19. Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins
20. Purified human neuromelanin, synthetic dopamine melanin as a potential model pigment, and the normal human substantia nigra: Characterization by electron paramagnetic resonance spectroscopy
21. The roles of neuromelanin, binding of metal-ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease. An hypothesis
22. Aging and Parkinson's disease: Substantia nigra regional activity
23. On the nature of pigment granules in the cell of the locus coeruleus and substantia nigra
24. Iron in parkinsonian and control substantia nigra, a Mössbauer spectroscopy study
25. Mössbauer spectroscopic studies of human neuromelanin isolated from the substantia nigra
26. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease
27. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra and differential cell death in Parkinson's disease
28. Neuromelanin containing neurons of the substantia nigra accumulate iron and aluminium in Parkinson's disease: A LAMMA study
29. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson disease
30. On the origin and significance of neuromelanin
31. Biochemical pathophysiology of Parkinson's disease
32. Does tyrosinase exists in neuromelanin pigmented neurons of human substantia nigra?
33. Iron-melanin complex in substantia nigra of Parkinsonian brains: An x-ray microanalysis
34. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson disease related to their neuromelanin content?
35. XAFS studies of iron sites in synthetic and natural neuromelanin
36. Preservation of midbrain catecholaminergic neurons in very old human subjects
37. 14C] diquat in frogs and mice: Accumulation in neuromelanin
38. Lipoprotein pigments- their relationship to aging in the human nervous system. II. The melanin content of pigmented nerve cells
39. Possible role of neuromelanin in the pathogenesis of Parkinson's disease
40. Pigmentation in the nuculeus substantiae nigrae of mammals
41. Enzyme activity of macrophage migration inhibitory factor toward oxidised catecholamines
42. Aging and extrapyramidal function
43. Absence of ferritin protein in substantia nigra pars compacta neurons. A reappraisal to the role of iron in Parkinson disease pathogenesis
44. Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India
45. Neuromelanin of the human substantia nigra: A mixed type melanin
46. Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the aetiology of Parkinson disease
47. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method
48. Titanium Nitride as a coating of surgical instruments to collect human tissues for trace analysis
49. Detection of 5-S-cysteinyldopamine in human brain
50. Trace elements reference values in tissues from inhabitants of the European Community. II. Example of strategy adopted and trace elements analysis of blood, lymphonodes and cerebro- spinal fluids of italian subjects
51. Binding of dopaminergic drugs by the neuromelanin of the substantia nigra, synthetic melanins and melanin granules
52. Structure and chemical reactivity of metal-ion complexes with neuromelanin
53. Melanin pigmentation of the substantia nigra in primates
54. The binding of iron to neuromelanin and synthetic melanin: An electron paramagnetic resonance spectroscopy study
55. On the function of neuromelanin
56. Increased iron (III) and total iron content in post-mortem substantia-nigra of Parkinsonian brain
57. Modulation by melanins of the availability and reactivity of metal ions
58. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles
59. New evidence for presence of tyrosinase in substantia nigra, forebrain, and midbrain
60. Biochemistry of neuromelanin
61. Spectroscopic studies of substantia nigra pigment in human subjects
62. Cysteinyldopamine is not incorporated into neuromelanin
63. Tyrosinase mRNA is expressed in human substantia nigra
64. The effect of synthetic neuromelanin on yield of free hydroxyl radicals generated in model system
65. Total and paramagnetic metals in human substantia nigra and its neuromelanin
66. The chemical characterization of melanin contained in substantia nigra of human brain
67. Iron and other metals in neuromelanin, substantia nigra and putamen of human brain
68. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain
69. The interaction of human substantia nigra neuromelanin with lipids and peptides
70. Iron, neuromelanin and ferritin in substantia nigra of normal subjects at different ages. Consequences for iron storage and neurodegenerative disorders
71. Combined biochemical separation and INAA for the determination of iron and other metals in neuromelanin of human brain